[Form 4] Option Care Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Adewunmi Femi reported acquisition or exercise transactions in this Form 4 filing.

Option Care Health, Inc. Chief Medical Officer Femi Adewunmi received a grant of 9,579 shares of common stock as an equity award. After this award, total directly held shares are 28,337. The restricted stock units vest in three equal annual installments on each of the first, second, and third anniversaries of the grant date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Adewunmi Femi

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		A		9,579(1)	A	$0	28,337	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

	/s/ Michael Bavaro, attorney-in-fact for Mr. Adewunmi	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Option Care Health (OPCH) report for Femi Adewunmi?

Option Care Health reported that Chief Medical Officer Femi Adewunmi received an equity award of 9,579 shares of common stock. This was a grant, not an open-market purchase or sale, increasing his directly held stake in the company.

How many Option Care Health (OPCH) shares does Femi Adewunmi hold after this Form 4 grant?

After the reported equity grant, Chief Medical Officer Femi Adewunmi directly holds 28,337 shares of Option Care Health common stock. This total reflects the newly awarded 9,579 shares included in the Form 4 insider transaction report.

What does the 9,579-share award to OPCH’s Chief Medical Officer represent?

The 9,579-share award represents restricted stock units granted to Option Care Health’s Chief Medical Officer as compensation. These RSUs convert into common shares over time as they vest, aligning part of his pay with the company’s long-term performance.

How do the restricted stock units granted to OPCH’s CMO vest over time?

The restricted stock units granted to the Chief Medical Officer vest in three stages. One third of the underlying common shares vests on each of the first, second, and third anniversaries of the grant date, subject to continued service conditions.

Was the OPCH Form 4 transaction a stock purchase or sale by the insider?

No, the transaction was not a market purchase or sale. It was reported as a grant or award acquisition of 9,579 restricted stock units, meaning the shares were awarded as part of compensation rather than bought or sold in the open market.

What role does Femi Adewunmi hold at Option Care Health (OPCH) in this Form 4?

In this Form 4, Femi Adewunmi is identified as the Chief Medical Officer of Option Care Health. His position helps explain why he received a restricted stock unit grant as part of his compensation and long-term incentive package.